Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04011644 · ClinicalTrials.gov registry record · NA
Mobile Health for Alcohol Use Disorders in Clinical Practice
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 558
- Enrollment target
NCT04011644: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT04011644 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 558 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04011644, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 558 participants
- Enrollment target
Study Summary
This study evaluates the impact on risky drinking days and quality of life for patients with alcohol use disorder among patients who use a mobile health smart phone application. A third of the participants will receive access to the smart phone app without any monitoring; a third of the participants will receive access to the smart phone app monitored by and connected with a peer mentor; a third will receive access to the smart phone app monitored by and connected with a health coach who works within a healthcare system.
Primary Outcome
Percentage of self-reported Heavy Drinking Days (HDD: 5 or more standard drinks on any day for men under 65, 4 or more standard drinks for women and men over 65) in the last 7 days
Interventions
- BEHAVIORAL A-CHESS self-monitored
- BEHAVIORAL A-CHESS peer-supported
- BEHAVIORAL A-CHESS clinically-integrated
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 558 participants |
| Start Date | 2020-03-23 |
| Est. Completion | 2024-01-22 |
| Phase | NA |
What the finished NCT04011644 record still lists
NCT04011644 is an interventional study that assigns participants to a tested intervention. The registered 558 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 3 interventions - of which A-CHESS self-monitored is the first listed.
NCT04011644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04011644 about?
NCT04011644 is a clinical study titled "Mobile Health for Alcohol Use Disorders in Clinical Practice". This study evaluates the impact on risky drinking days and quality of life for patients with alcohol use disorder among patients who use a mobile health smart phone application. A third of the participants will receive access to the smart phone app without any monitoring; a third of the participants...
What is the current status of trial NCT04011644?
This trial is currently completed. It is a NA study. The enrollment target is 558 participants. The study started on 2020-03-23. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT04011644?
The interventions under investigation include: A-CHESS self-monitored (BEHAVIORAL), A-CHESS peer-supported (BEHAVIORAL), A-CHESS clinically-integrated (BEHAVIORAL).
Who is sponsoring clinical trial NCT04011644?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04011644's enrollment target sits among peer trials
558 183rd of 2000 higher than 1,818 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07173751 · 558 participants · Phase 3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI